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Abstract
The anti-invasive and anti-proliferative effects of betulins and abietane derivatives was sys-
tematically tested using an organotypic model system of advanced, castration-resistant
prostate cancers. A preliminary screen of the initial set of 93 compounds was performed in
two-dimensional (2D) growth conditions using non-transformed prostate epithelial cells
(EP156T), an androgen-sensitive prostate cancer cell line (LNCaP), and the castration-re-
sistant, highly invasive cell line PC-3. The 25 most promising compounds were all betulin
derivatives. These were selected for a focused secondary screen in three-dimensional (3D)
growth conditions, with the goal to identify the most effective and specific anti-invasive com-
pounds. Additional sensitivity and cytotoxicity tests were then performed using an extended
cell line panel. The effects of these compounds on cell cycle progression, mitosis, prolifera-
tion and unspecific cytotoxicity, versus their ability to specifically interfere with cell motility
and tumor cell invasion was addressed. To identify potential mechanisms of action and like-
ly compound targets, multiplex profiling of compound effects on a panel of 43 human protein
kinases was performed. These target de-convolution studies, combined with the phenotypic
analyses of multicellular organoids in 3D models, revealed specific inhibition of AKT signal-
ing linked to effects on the organization of the actin cytoskeleton as the most likely driver of
altered cell morphology and motility.
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Introduction
Apart from skin cancer, prostate cancer (PrCa) is the most common cancer in men, especially
in Europe. PrCa is typically hormone-dependent and the role of androgens in the progression
from androgen-dependent to hormone-refractory PrCa is well established [1]. Early-stage
PrCa can be successfully managed by operation alone and recurrent tumors are treated by abla-
tion of circulating androgens by chemical castration. In contrast, late-stage castration-resistant
PrCa (CRPC) with characteristic metastatic dissemination of the primary tumor, usually to the
bone, remains the major cause of cancer-associated death. Although significant progress has
been made in the treatment of primary and androgen-sensitive prostate tumors, curative thera-
pies that specifically target the metastatic spread of advanced and aggressive CRPC currently
do not exist. Partly, this is related to the lack of experimental model systems that faithfully rep-
resent the features of invasiveness and cell motility in vitro or in vivo.
Neither standard two-dimensional (2D) cell culture models (cell lines) nor animal models
(mouse xenografts) accurately represent the full complexity of clinical tumors. 2D models par-
ticularly lack the tumor microenvironment (TME), the extracellular matrix (ECM), and stro-
mal cell types. Such models only poorly correspond with drug sensitivity observed in vivo [2].
These functional shortcomings of pre-clinical drug discovery are reflected by the high attrition
rates for cancer drugs (>95%) [3] in subsequent clinical studies. Thus, biologically more rele-
vant in vitro tumor models need to be developed to improve productivity of drug discovery
and reduce the number of animals required in drug development [4]. ECM preparations from
different origins have proven particularly critical to investigate cell-cell interactions and differ-
entiation in 3D culture [5]. Integrated, robust and standardized 3D platforms have become
compatible for both high-throughput (HTS) and high-content screening (HCS) settings [2],
and the efficient translation of 3D cell culture methods from basic research to industrial appli-
cations is ongoing [6]. Biologically relevant ECM such as collagens or laminin-rich basement
membrane extracts like Matrigel are now widely used to study cellular mechanisms such as cell
motility and invasion. The spectrum of multicellular morphologies formed by prostate epitheli-
al and cancer cells in 3D cultures ranges from fully functional glandular acini, dysfunctional
tumor spheroids; to invasive stellate structures [7,8] that lack most differentiated properties.
Thus, the different morphology manifested in 3D lrECM culture is a solid indicator that corre-
lates with various stages of malignant progression. Such biomimetic 3D cell models provide a
powerful means to quantify cancer-related biological processes. Invasion and metastasis are the
most critical hallmarks of cancer that can transform localized cancer into a life-threatening dis-
ease [9]. In 3D culture, tumor cell invasion is manifested either by single cells or cell aggregates
that actively invade the surrounding ECM, using different modes of motility (e.g. amoeboid or
collective invasion) [10]. PC-3 is one of the few PrCa cell lines that displays collective invasion
characteristics both in vitro and in vivo [7,11]. Such complex multicellular processes cannot be
reproduced in anchorage-independent, non-adherent 3D systems that lack biologically func-
tional ECM, such as poly-HEMA [12], soft agar [13] or “hanging-drop” cultures of isolated
spheroids [14]. A recent study showed that gene expression profiles of breast cancer cells cul-
tured in 3D lrECM were much closer to in vivo than monolayer or poly-HEMA cultures [15].
High content screens (HCS) using lrECM-based platforms have been reported for prostate
[16], breast [15], pancreatic [17], and ovarian cancers [18]. Such thoroughly standardized and
miniaturized tissue-like models are required to systematically capture the effects of small mole-
cule compounds/drugs, siRNAs, biological (e.g. antibodies and peptides), growth factors, or
toxins on tumor biology. These complex biomimetic approaches are useful as faithful pre-clini-
cal tools for investigating short- and long-term drug responses, therapy failure, or development
of drug resistance [19]. Combined with high-content microscopic imaging and image-analysis
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methods, 3D phenotypic models can also be highly informative for lead discovery and lead
optimization studies (LD or LO, respectively), in particular if the molecular drug target is un-
known, and complex mechanisms such as tissue-specific differentiation, and cell-cell-interac-
tions can be assessed based on unbiased, multiparametric read-out. Multiplexing of imaging-
based readout also enables the simultaneous assessment of cytotoxicity, apoptosis, and effects
on the cell cycle, e.g. by using appropriate fluorescent probes [2,20], thus reducing the need for
excessive validation studies. In addition, real-time and live cell 3D assays based on high-con-
tent image analysis can be combined with endpoint studies addressing the expression of bio-
markers, as described in previous publications [7,11].
Natural products (NPs) have been invaluable as tools for deciphering the logic of biosynthe-
sis and as starting materials for developing front-line drugs [21]. Indeed, the majority of new
chemical entities approved as drugs by the US Food and Drug Administration (FDA) have
consistently been either NPs or NP-derived compounds [22]. The pentacyclic triterpenoids,
secondary plant metabolites abundantly found in fruit peel, leaves and stem bark, have at-
tracted great interest as therapeutic agents and dietary supplements [23,24]. In addition, semi-
synthetic derivatives of the naturally occurring triterpenoids have been actively studied in
search for new anticancer agents, with specific focus on anti-invasiveness properties [24–29].
Betulin and betulinic acid are lupane-type pentacyclic triterpenes abundant in the bark of birch
species of the genus Betula L. [30]. Betulinic acid and other betulin derivatives have antiviral,
anti-inflammatory, anti-malarial, and anti-cancer effects [31]. In addition, betulinic acid was
identified as a selective inducer of apoptosis in melanoma cells [32], triggering a strong interest
in triterpenes as anticancer agents. Moreover, betulin was found to block the invasive proper-
ties of brain and lung cancer cells, well below its cytotoxic concentration, suggesting a promis-
ing chemopreventive effect against metastases [33]. In the present study, we have used a
combination of 2D and 3D PrCa cell models and HCS methods based on imaging and auto-
mated image analysis, to assess and validate the antineoplastic and anti-invasive properties of a
library of 93 compounds. In this library, we have included the parental compounds betulin,
betulinic acid (2) and their semi-synthetic derivatives, and compounds from another class of
terpenoids with less studied biological effects, the abietanes. Overall, the library comprised 78
betulins and 15 abietanes.
Results and Discussion
Synthesis of a library of betulin and abietane derivatives
A set of 76 betulin derivatives was prepared starting from betulin and betulinic acid (1), where-
as 13 derivatives were prepared from dehydroabietic acid and dehydroabietylamide (Figs 1–3,
see also S1 File), using our expertise on natural products chemistry and following either our
previously reported procedures or those of others [34–37]. Betulonic acid (2) was obtained
from betulin by Jones oxidation, and used as a versatile intermediate for chemical syntheses.
Different substituents were inserted into the positions 3 and 28 of the lupane core. Some deriv-
atives were also prepared by fusing heterocycles to ring A, at positions 2 and 3. Other com-
pounds contained one extra ring fused to rings C, D and E. Reduction of the isoproprenyl side
chain of the triterpene core was done for some of the derivatives. Side-chain rearrangement re-
sulted also in germanicane-type compounds. In the abietanes set the compounds prepared con-
sisted mostly of urea and amide derivatives.
High Throughput Screening (HTS) for bioactivity
These compounds were compiled as a library and biological activity was tested using 2D cell
cultures in 384-well plates in high throughput screening (HTS) format (S1 Fig). The cell lines
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Fig 1. Chemical structures of the parental compound betulinic acid and its derivatives.
doi:10.1371/journal.pone.0126111.g001
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Fig 2. Chemical structures of the fused 5-membered ring derivatives of betulinic acid.
doi:10.1371/journal.pone.0126111.g002
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Fig 3. Chemical structures of the fused 6-membered ring derivatives of betulinic acid.
doi:10.1371/journal.pone.0126111.g003
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used were EP156T (non-transformed prostate epithelium), LNCaP (androgen sensitive PrCa),
and PC3 (castration-resistant, invasive PrCa). The experiments were performed in three differ-
ent compound concentrations (0.1, 1 and 10 μM) in triplicate, using CellTiterGlo as an end-
point read-out for cell proliferation. A panel of 25 betulin derivatives was synthesized accord-
ing to the most effective and cancer-specific compounds identified in the preliminary 2D
screen, and selected for further studies.
High Content Screening (HCS) for invasion-blocking activity
Next, these 25 most effective compounds were tested in 3D settings for specific anti-invasive
properties. Three standard of care compounds widely used against PrCa were added as con-
trols; namely, the androgen receptor antagonist enzalutamide (MDV3100), the C17α-hydroxy-
lase/C17,20-lyase inhibitor abiraterone (Zytiga), and the classic mitotic inhibitor paclitaxel.
Treatments started at day 4, when well-differentiated round acini were established. Compound
exposure was then continued for six days, when most of the untreated multicellular structures
had transformed into a highly invasive phenotype.
Automated morphometric image analysis (AMIDA) and statistical
evaluation
The live 3D cell cultures were then stained with reactive dyes Calcein AM to detect living, and
ethidium homodimer to detect dead cells. Images (Fig 4A) were acquired with confocal micro-
scope and image data were analyzed with the AMIDA software [38]. The principles of morpho-
metric image analysis are briefly outlined in S2 Fig.
Fig 4A shows representative confocal microscope images for some of the betulin derivatives.
The highly effective, antimitotic control drug paclitaxel stood out even at very low concentra-
tions (30 and 100 nM), showing a strong effect on all morphometric measures (Fig 4B): this re-
sulted in smaller (reduced area), less invasive organoids (reduced complexity), with increased
numbers of dead cells. The control compounds abiraterone and enzalutamide had no notice-
able effect on PC-3 cells. Interestingly, betulinic acid (1) and betulonic acid (2) did not show
significant anti-invasive effects, whereas compound 3, bearing an isopropyl substituent at C19,
was one of the most potent anti-invasive, growth inhibitory agents. Similarly, the isoxazole de-
rivatives 4 and 5 displayed strong growth inhibiting and anti-invasive effects at lower concen-
trations (as low as 100 nM for 4 and 300 nM for 5). All of these effective compounds differ
only at position C19: compound 4 has an isopropyl side-chain, while compound 5 has the orig-
inal isopropenyl side-chain. Furthermore, when the isoxazole ring of 5 was replaced with a pyr-
azole ring, the resulting compound 6 was even more potent and proved to be specifically anti-
invasive. In contrast, the isoxazole derivatives with a formyl (7) or an acetoxy group (8), a pri-
mary amide (9) or a hydroxy (10) group at position C28 displayed negligible effects on the in-
vasive phenotype. The relevance of the original carboxyl group at position C28 (betulonic acid,
2) for anti-invasive or cytotoxic activity was studied by replacing this group with various amide
groups. None of these compounds showed significant anti-invasive effects (11, 12, 13, and 14)
(not shown). Also compound 15 showed strong anti-invasive effects at 1.0 μMwithout any
growth inhibition. However, when its carboxyl group at C17 was converted into a primary
amide group, the resulting compound 16 had the same high level of anti-invasive effects as
compound 15. In contrast, derivatives with tertiary amide (17) or nitrile groups (18) at C17
were inactive (not shown). Two pyridine derivatives were also tested. No loss in anti-invasive
activity was observed whether the pyridine nitrogen was adjacent to the C3 position of the orig-
inal lupane skeleton (19), or next to the C2 position of the lupane skeleton (20). Interestingly,
Anti-Invasive Properties of Betulin Derivatives
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both compounds 19 and 20 were potently anti-invasive at significantly lower concentrations,
compared to compound 15.
Next, statistical analyses were performed to interpret the complex image data (Fig 4B and
4C). For simplicity, we focused on only three, basic morphologic parameters from the multi-
parametric AMIDA readout (Fig 4B): 1) Area (indicating growth of organoids), 2) structural
Complexity (as a measure of the intensity of invasion), and 3) Relative Area of dead cells with-
in organoids (red signal as a measure of cytoxicity or apoptosis). Area (Size of organoids; Fig
4B, upper panel) was measured as the number of pixels within a segmented structure. The loga-
rithmic transformation of Area/Size data was used, which showed a close to Gaussian (normal)
distribution within the images. Shape Complexity (Fig 4B, middle panel) was obtained using
the structure size (area) and perimeter (number of border pixels). The more regular the shape
of an organoid, the closer it is to a perfect circle, thus minimizing the perimeter relative to ob-
ject size. We observed a close to linear dependency between log(Area) and log(Perimeter), indi-
cating a natural (functional) relationship between these two features. Fitting a regression line
to the data resulted in a useful estimate of the average perimeter of any organoid structure. De-
viations from this average (residuals) were interpreted as a measure for the shape complexity of
organoids. As a logical lower limit for this measure (represented by a perfect circle), we adjust-
ed the intercept (height level) of the regression line to render all returned residuals as positive
numbers. This simplified, rapid measure of the multicellular complexity indicated that the log-
arithm of residuals results in an almost symmetrical distribution of values. Hierarchical cluster-
ing, using these three basic measures from PC3 cultures yielded a simple dendrogram with two
main branches: the first cluster included the most potent anti-proliferative and anti-invasive
compounds (Fig 4C: yellow). The second cluster represents weak (Fig 4C: red) and non-effec-
tive (Fig 4C: grey) compounds.
Validation of anti-invasive properties
Based on the primary screen, we selected six betulin derivatives for further validation of the
anti-invasive effects by additional methods. In a standard wound healing assay performed in
monolayer 2D culture, the efficacy of some compounds was strikingly different to 3D settings.
For example, compounds 4, and 20 completely reduced invasion in 3D already at 300 nM, re-
spectively (Fig 4A), but showed only 50% reduction of wound closure after 64 hours (Fig 4D)
at the same concentration. Also, compound 5 effectively inhibited invasive transformation of
PC-3 spheroids already at 300 nM in 3D (S3A Fig),measured as “% roundness” retained after
10 days), but concentrations higher than 1 μMwere required in 2D culture for comparable ef-
fects (S3B Fig). Also the most potent anti-invasive agents 6, 16 and 19 (active at 100 nM in 3D
conditions) reduced wound closure in 2D only by 50% at 3 μM and 1 μM, respectively (S3B
Fig). Compound 21 is included here as an example for inactive derivatives. The fact that many
compounds lacked the same potency in the conventional 2D monolayer culture suggests that
the biological targets or pathways involved in cell motility are not equally active in cell migra-
tion on plastic surfaces. It is also likely that cell motility in 2D monolayer culture is controlled
by other mechanisms than collective invasion in a 3D scaffold.
Fig 4. Primary 3D screen. PC-3 cells were cultured in 3D Matrigel ECM for 4 days and treated for 6 days with 25 betulin derivatives (from 2D high
throughput screens), DMSO/vehicle control, and three reference compounds. A) Representative maximum intensity projections of confocal microscope stack
images for selected compound treatments at 300 nM concentration (5× objective, scale 100 μm). B) Three graphs showing the relative impact on three
morphometric parameters for 7 betulin derivatives, DMSO control, and one control compound (paclitaxel). Data scaling: displays the relative difference
between median of Area/Complexity/Area Ratio, to DMSO control. Paclitaxel treatments and DMSO controls have been assigned values of -100 and 0,
respectively. C) Hierarchical clustering was done using three morphological parameters derived from PC3 organoids: spheroid size (area), complexity and
the number of dead cells. D) Wound healing curves of the two betulin derivatives 4 and 20, highlighting the 50% cut-off level (orange dashed line).
doi:10.1371/journal.pone.0126111.g004
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Secondary 3D screens. Next, the 25 selected betulin derivatives depicted in Figs 1–3 in-
cluding control compounds were again thoroughly tested across the same panel of prostate-de-
rived cell lines already used in the preliminary, 2D high-throughput screen. The resulting
dendrograms were either generated separately for each cell line (S4 Fig), combined into a single
dendrogram (Fig 5A), or shown as reduced organoid sizes (area; Fig 5B). In the non-invasive,
but hormone-sensitive LNCaP organoids, most compound effects were relatively mild. Non-ef-
fective treatments comprise the vast majority of the graph (S4 Fig: grey), while the few effective
compounds fall into two connected branches (yellow and red). As expected, the androgen an-
tagonist enzalutamide but not abiraterone were among the effective treatments. Paclitaxel clus-
ters together with betulin derivatives at higher concentrations—these compounds were also
effective on hormone resistant, invasive PC-3 cells. The dendrogram for hormone dependent,
non-invasive LAPC-4 (S4B Fig) again demonstrates the efficacy of all positive controls (abira-
terone, enzalutamide and paclitaxel; within yellow and red clusters). The most active betulin
derivatives again fall inside these same clusters (3, 4, 6, 16, 19 and 20) adjacent to positive con-
trols. In contrast to PrCa cell lines, the non-transformed, normal-like Ep156T cell line (S4C
Fig) also responded to betulonic acid (2), at least at the highest concentration. In general, as
with LNCaP and LAPC4 cells, the effects on Ep156T growth were mild (Fig 5B).
In order to assist functional categorization of our betulin derivatives, we combined all data
into a single dendrogram, shown in Fig 5A. In addition, multiparametric representation of all
experimental data as a single heatmap is highly informative (S5 Fig) and a potent way to illus-
trate the effects of compounds on growth, structural complexity and cell death across multiple
cell lines. We divided the compounds and controls into three clusters: 1) growth inhibitory
compounds, 2) strong and weak anti-invasive compounds, and 3) inactive compounds. The
morphological effects in 3D culture are summarized in S6 Fig The most potent anti-invasive
effects (on PC-3 cells) were shown by compounds 3, 4, 6, 15, 19 and 20, at concentrations of
300 nM or lower (with the exception of compound 15), with no noticeable effects on the other
cell lines. Most of these compounds, however, showed growth-inhibitory effects in all cell lines
at concentrations of 1 μM or higher. In conclusion, many betulin derivatives are cytotoxic and
inhibit cell growth at high concentrations (>1 μM). However, at lower concentrations, these
compounds may act as potent and specific inhibitors of cell invasion and motility.
Estimation of anti-invasive vs cytotoxic activity. To rule out that cytotoxic and antimitot-
ic effects were misinterpreted as anti-invasive, we tested compounds 4, 5, 6, 19 and 20 for inhibi-
tion of proliferation and induction of cell death in a 2Dmonolayer culture (summarized in Fig
6). A broad range of compound concentrations (1 nM to 30 μM) were used for PC-3, LNCaP
and Ep156T cell lines, and analyzed with the PerkinElmer Operetta high-content imager. In PC3
cells, most compounds did not show noticeable effects on proliferation at concentrations lower
than 10 μM (Fig 6A). LNCaP cells were more sensitive, with growth inhibition/cytotoxicity start-
ing at 3 μM. The effects on non-transformed, apoptosis-sensitive Ep156T cells were strongest.
Here, cytotoxic effects were typically observed already at 0.3–1 μM. None of the compounds spe-
cifically induced cell death in PC-3 or LNCaP cells at concentrations below 30 μM (Fig 6B and
6C; except for compound 19). We further calculated EC50 values for proliferation, apoptosis and
cell death for each compound, using the PerkinElmer Harmony software (method validation
shown in S7 Fig). The only assay that produced results consistent with those of the betulin deriv-
atives tested in the 2D cell culture model was the proliferation assay (Table 1).
Effects on cell cycle progression and mitosis
We next tested if the betulin derivatives had specific effects on cell cycle progression and mito-
sis at concentrations of 300 nM (not shown) and 1 μM in 2D culture (Fig 6D and S8 Fig).
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Fig 5. Secondary 3D screens. Experimental betulin derivatives and control compounds were tested across a panel of prostate cancer lines (LNCaP, LAPC-
4) and non-transformed, prostate epithelial cells (EP156T) in 3D culture.A) The dendrogram is based on three main morphological parameters and
combines all data from primary and secondary 3D screens. Effective compound treatments are indicated in red and yellow, yellow being the most invasion-
specific.B) Boxplots showing the impact of selected compounds on spheroid size (Area). Data scaling: as described in Fig 4 C) Effects of all betulin
derivatives and control compounds on cell death (number of dead cells).
doi:10.1371/journal.pone.0126111.g005
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Fig 6. Cytotoxicity tests performed in 2Dmonolayer culture. A) Cell proliferation/cell number,B) programmed cell death (apoptosis), andC) number of
dead cells were assessed by conventional assays, combined with high-content microscopy (Operetta). Cells were treated with the five most effective betulin
derivatives, including paclitaxel control for 72h. Proliferation was measured as the total number of nuclei (= cells), apoptosis as ratio of caspase-3 positive
versus all cells, and cell death as ethidium homodimer-2 positive nuclei versus all cells.
doi:10.1371/journal.pone.0126111.g006
Table 1. Estimated EC50 values for cell proliferation.
PC-3 LNCaP EP156T
Compound 6 90.8 6.4 0.21
Compound 5 9.5 64.6 0.22
Compound 4 55.9 93.1 0.2
Compound 19 86.9 0.9 0.18
Compound 20 66.9 131.5 0.19
Paclitaxel 0.0012 0.0006 0.0008
Values have been calculated using Harmony High-Content Imaging and Analysis Software.
doi:10.1371/journal.pone.0126111.t001
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There were no noticeable differences in cell cycle progression in response to any of the tested
compounds. We also assessed cell proliferation and mitosis by measuring PCNA and cyclin B1
protein levels (S8B Fig). As expected, betulin derivatives showed no effect on the expression of
either protein at the concentration tested. These findings again support that betulin derivatives
are only cytotoxic or cause DNA damage at high concentrations (PrCa EC50 values ranging
from 1–90 μM), whereas they promote considerable anti-invasiveness effects at low
nanomolar concentrations.
Possible mechanism(s) of action of the betulin derivatives. In order to elucidate possible
mechanism of action for our betulin derivatives, we used a phospho-kinase array that quantita-
tively detects the phosphorylation levels of 43 kinases in cell lysates (Fig 7). Lysates were ex-
tracted from 3D cell cultures of PC-3 cells, and exposed to betulin-derived compounds for
short (4 hours) or long-term (6 days) periods. For these studies, we selected the two representa-
tive derivatives 5 and 20 as the most specific, least cytotoxic inhibitors of cell invasion. The
short-term (4 h) exposure was performed at a relatively high concentration of 1 μM, whereas
for the long-term (6 d) exposure, a concentration of only 300 nM was used; both well below the
cytotoxic EC50 values (10 μM for compound 5 and 67 μM for compound 20). The kinase arrays
were also quantified by image densitometry (Fig 7A). Phosphorylation levels of four kinases, in
both short and long-term exposures, were clearly decreased: STAT3 (Y727), c-Jun (S63), eNOS
(S1177) and PLC-γ1 (Y783) (Fig 7A top and bottom panels). Both compounds also reduced
p53 (S15) phosphorylation in the short-term exposure and p70 S6 kinase (T389), p53 (S392)
and PYK2 (Y402) phosphorylation in the 6-d exposure, and increased AMPKα1 (T174) phos-
phorylation. Compound-specific effects for substance 20 included differential phosphorylation
of Hck (Y411), pan-JNK, GSK-3α/β (S21/S9), STAT3 (Y705) andWNK1 (T60) sites. Akt
(S473) phosphorylation was only inhibited by the 6-d exposure. Compound 20 also increased
the phosphorylation of mTOR (S2448), Fyn (Y420) and Src (Y419). In contrast, compound 5
did not cause any specific changes in kinase activity in the short-term exposure, and showed
only few distinct changes in the long-term treatment. Most notably, Akt (T308) phosphoryla-
tion was also abolished almost entirely in response to exposure with compound 5, whereas the
phosphorylation of p53 sites S46 and S392 were consistently decreased (Fig 7A). The reduction
of AKT activity by both compounds was validated by western blotting, using an independent,
p-AKT specific antibody (Fig 7B). The short treatments caused only modest changes with a
maximum reduction of protein phosphorylation by 2-fold (20: GSK-3α/β S21/S9 and STAT3
Y705). Phosphorylation levels of only three kinases were altered more than 2-fold in the long-
term exposures, namely AKT (T308), p53 (S46) and eNOS (S1177), caused by nanomolar con-
centrations of compound 5. Compound 20 had much less dramatic effects on kinase phosphor-
ylation when compared to compound 5, despite its generally more pronounced anti-invasive
effects. In summary, the observed reduced AKT and p53 activity as well as the altered phos-
phorylation levels of several proteins including eNOS, pan-JNK, and GSK-3α/β, suggest decel-
erated cell metabolism or decreased cell viability.
We also explored the 3D multicellular morphologies of PC-3, LNCaP and Ep156T spher-
oids exposed to the 5 selected betulin derivatives both for short and long periods of 4 hours
and 6 days. From a detailed analysis of the F-actin cytoskeleton (phalloidin staining), it became
evident that compounds 5, 6, 15 and 20 effectively disrupted the organization of actin cytoskel-
eton after 48 hours of exposure (Fig 8A). Interestingly, an almost identical actin “corkscrew”
phenotype was seen in the normal Ep156T acini and PC-3 spheroids (Fig 8A: magnification
panel on the right) whereas the typical cortical actin organization in LNCaP spheroids re-
mained intact. This suggests that these betulin derivatives may target relevant pathways in aci-
nar morphogenesis and dynamic processes involved in cell motility (also EP156T cells form
dynamic “branching” structures that penetrate the ECM). For phenotypic comparisons, we
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tested a panel of reference compounds targeting Akt, Rac, ROCK, Src, and other pathways,
broadly linked to the actin cytoskeleton. None of the tested control compounds affected the cy-
toskeleton in a comparable fashion, with the exception of the non-specific, pan-kinase inhibitor
staurosporine. However, these effects were not uniform across the panel of cell lines (Fig 8B,
magnification on right).
As a control, we also tested morphologies treated with the same panel of anti-invasive com-
pounds 4, 5, 6, 16 and 20 as well as betulin (1) on PC3 cells grown in 2D monolayer cultures
(S9 Fig). No morphologies and visible effects on the actin cytoskeleton as seen in 3D settings
were observed in 2D growth conditions. In contrast, blocking Rac (IPA3 compound) or Rho
Kinase/ROCK signaling (Y-27632) did result in a clear rounding (IPA3) or elongation (Y-
27632) of single PC3 cells. This indicates that mechanisms affecting the actin cytoskeleton and
Fig 7. Mechanisms of action. PC-3 spheroids were exposed to two representative betulin derivatives, 5 and 20, for 4 h (at 1 μM) and 6 days (at 0.3 μM). A)
Computational quantification of signal intensities from the kinase arrays, aligned by fold changes observed (left to right). B) Western blot of total and
phospho-Akt (S473) shown for both short and long-term exposure to 20 and 5.
doi:10.1371/journal.pone.0126111.g007
Fig 8. 3Dmorphologies of prostate spheroids, exposed to selected betulin derivatives and captured with a confocal microscope. Actin cytoskeleton
(filamentous or F-actin) is stained green (phalloidin), nuclei with a red dye (confocal microscope images, 40× objective, scale bar shown for each panel on the
right lower corner).
doi:10.1371/journal.pone.0126111.g008
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cell motility by particularly anti-invasive betulin derivatives may a) not apply in 2D conditions
and b) may not function via the Rho and Rac signaling pathways.
Conclusions
The morphological and functional effects of a diverse set of betulin and abietane derivatives on
a selected panel of prostate cancer cell lines were analyzed using both routine 2D and, for a fo-
cused panel of 25 betulin derivatives, organotypic 3D cell culture models, by image-based high-
content analysis. Our data highlighted the dose-dependent, potent and robust anti-invasive ac-
tivity of some betulin derivatives at nanomolar concentrations, with minimal cytotoxicity.
Compounds bearing heterocyclic rings fused to ring A including pyrazine, pyrazole, oxazole,
indole, and pyridine moieties, were among the most promising in suppressing PC-3 cell inva-
siveness. A free carboxyl group at C28 was important for their activity, which was considerably
improved when compared to the parent betulinic acid. Kinase phosphorylation profiling, per-
formed for two representative betulin derivatives (5 and 20), suggested that these compounds
do not primarily affect cell cycle progression and mitosis, but induce cytotoxic stress only at
higher concentrations and after long exposure times, as indicated by p53 de-phosphorylation.
Direct evidence for DNA damage was not found. Both compounds reproducibly decreased
AKT phosphorylation. In line with the effects on AKT phosphorylation, we noticed that many
betulin derivatives, including 5 and 20, effectively disrupted actin cytoskeleton organization,
resulting in a peculiar corkscrew-like phenotype of the filamentous actin. This mechanism may
be causally linked to the efficient suppression of the invasive properties of PC-3 cells in both
2D and 3D conditions. Overall, our findings suggest that betulin-derivatives such as 5 and 20
may specifically target cell motility and invasion by affecting the organization of filamentous
actin fiber network at low nanomolar concentrations, without significant cytotoxic effects. Our
study greatly contributed towards establishing the true biological effects of betulin derivatives
on prostate cancer cells, with focus on invasiveness, by integrating chemical synthesis with 3D
screening platforms. They also highlight the role of betulin and betulinic acid as leads for the
development of potent and specific anti-invasive agents. The implementation of these plat-
forms in drug discovery programs could significantly contribute towards finding more selective
and thus less toxic treatments for cancers where metastasis is particularly relevant such as
those of the prostate.
Materials and Methods
Compound synthesis
Chemical synthesis and characterization data of the betulin and abietane derivatives is de-
scribed elsewhere, except for three novel compounds. The chemical synthesis and characteriza-
tion of the novel compounds and chemical structures of all the other compounds, which are
not included in Figs 1–3, are described in detail in S1 File. Chemical formulas of the most po-
tent 25 betulin derivatives are shown in Figs 1–3, whereas the other betulin and abietane deriv-
atives screened in this study are depicted in the Supporting Information (including additional
figures).
Cell lines and culture conditions
Cell lines were obtained from American Type Culture Collection (PC-3 and LNCaP, Manassas,
VA, USA) or originator laboratories (EP156T; Varda Rotter, Rehovot, Israel). PC-3 and
LNCaP cell lines were propagated in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO,
USA), EP156T cells were cultured in Keratinocyte Serum-Free Medium (KSFM; Invitrogen,
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Carlsbad, CA, USA), supplemented with 50 mg/L bovine pituitary extract, 5 mg/L epidermal
growth factor (EGF) and 2% fetal bovine serum (FBS) for 3D conditions.
Primary cell-based screens in 2D culture. Cell culture in 384-well plate format and high-
content screening were performed as described in [16].
Cell-based screens in 3D culture. All 3D cultures were done in growth factor-free Matri-
gel Basement-membrane Matrix (Corning Inc., New York, NY, USA) using 96-well
Angiogenesis μ-plates (ibidi GmbH, Munich, Germany) as described before.[38] “Sandwich”
assays in short: bottom wells of cooled Angiogenesis plates were filled with 10 μL 4 mg/mL
Matrigel, centrifuged for 20 min 200 g and incubated at 37°C temperature for approximately
30–60 min or until the ECM had polymerized. 1,000–1,500 cells were mixed in 2 mg/mL
ECM-medium, and 20 μL of cell suspension was added in each well. The plates were centri-
fuged for 10 min at 100 g, or until the cells had settled on top of the lower ECM. Finally, the
outer wells and side reservoirs were filled with water for humidification, and the culture plates
placed into the incubator for 3–4 h or overnight. The following day, 60 μL of cell culture medi-
um were added; refreshed every third day by carefully aspirating the medium. This “sandwich”
setting allows almost unifocal alignment of cells and 3D structures in a single optical plane,
thus reducing the time required for confocal stack imaging.
Morphometric image analysis (AMIDA), data normalization, and
mathematical/statistical modeling
Automated image analyses were essentially performed as described previously (S9 Fig).[38]
Statistical data processing and mathematical modeling of treatment responses are described in
depth in S1 File.
Chemicals and compound treatments
All control compounds were purchased from Selleck (Munich, Germany), except for stauros-
porine (Sigma-Aldrich, St. Louis, MO, USA) and Y-27632 (Tocris, Bristol, UK) and dissolved
in dimethyl sulfoxide (DMSO) as a vehicle at 10 mM. In the primary and secondary 3D
screens, experimental and control compound exposures were performed in triplicates. Four
concentrations for each compound were applied (0.03, 0.1, 0.3 and 1 μM). Compound treat-
ments were initiated four days after cell embedding, and continued for six days after which
spheroids were stained and imaged.
Image acquisition and pre-processing
3D cell cultures were double-stained with calcein AM fluorescent dye (Molecular Probes, Eu-
gene, OR, USA) and ethidium homodimer-2 (Invitrogen, Carlsbad, CA, USA). Confocal im-
ages were acquired with a Zeiss Axiovert-200M microscope, equipped with Yokogawa CSU22
spinning disc confocal unit using Zeiss Plan-Neofluar 5× objective. Intensity projections were
created with SlideBook (Intelligent Imaging Innovations Inc., Denver, CO, USA). Background
noise was removed by normalization, using either SlideBook or ImageJ (NIH, Bethesda, MD,
USA) programs.
Wound healing assay
Cells were cultured on ImageLock plates (Essen Bioscience, Ann Arbor, MI, USA) until fully
confluent and scratched with a WoundMaker instrument (Essen Bioscience). All detached cells
were removed by aspiration and medium supplemented with experimental compounds was
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added. Wound closure was monitored and quantified with the IncuCyte live-cell imager (Essen
Bioscience).
Proliferation, apoptosis and cell death assays
Cells were transferred into CellCarrier 384-well plates (PerkinElmer, Waltham, MA, USA) at a
density of 1250 cells/well, using Multidrop dispenser (ThermoFisher Scientific, Waltham, MA,
USA). After overnight incubation at 37°C experimental, compounds were added with an ATS
Acoustic Transfer System (EDC Biosystems, Fremont, CA, USA). For Ep156T cells the proto-
col was done in reverse with compounds dispensed before seeding of cells. Fluorescent markers
were dispensed in culture medium using ATS system after 72-h compound exposure. Nuclei
were stained with cell-permeable Hoechst 33342 (Molecular Probes, Eugene, OR, USA), dead
cells with ethidium homodimer-2 (Invitrogen, Carlsbad, CA, USA) and apoptotic cells with
NucView caspase-3 detection reagent (Essen Bioscience, Ann Arbor, MI, USA). Cells were im-
aged with Operetta high-content imager (PerkinElmer, Waltham, MA, USA). Proliferation was
measured from the number of nuclei (cells), cell death and apoptosis from positive cells/total
cells ratio using Harmony image analysis software (PerkinElmer, Waltham, MA, USA). EC50
values were also assessed with the Harmony software.
Cell cycle and DNA damage response analyses
Propidium iodide–based cell cycle analysis method was adapted fromMoores Cancer Center
protocol (UC San Diego). In short: cells treated for 72 h with experimental compounds on
6-well plates were washed, detached with trypsin, transferred into Eppendorf tubes, washed
first with medium and ice cold phosphate buffered saline, pH 7.4 (PBS). Between each step,
cells were spun down (200 g × 5 min at 4°C). Finally, cells were suspended in 0.5 mL ice cold
PBS and slowly added to 1 mL ice cold absolute ethanol. Pellets were stored at -20°C for at least
72 h, after which they were washed with PBS and stained with 50 μg/mL propidium iodide
(Molecular Probes, Eugene, OR, USA). DNA content of 10,000 cells/sample was measured
using a fluorescence-activated cell sorter BD FACSCalibur (BD Biosciences, Franklin Lakes,
NJ, USA). Cell cycle analyses were performed using the FCS Express 4 software (De Novo Soft-
ware, Los Angeles, CA, USA).
Antibody arrays
In order to generate sufficient protein material for antibody arrays, we resorted to 6-well Milli-
cell hanging cell culture inserts (Merck Millipore, Billerica, MA, USA). Membranes were pre-
coated with 4 mg/mL GFRMatrigel (Corning Inc., New York, NY, USA) and incubated at
37°C for 1 h to prevent attachment to the membrane. GFR Matrigel (2 mg/mL) was prepared
and 100,000 cells were added in. The Matrigel-cell suspension was transferred into the coated
wells and incubated overnight at 37°C. Fresh medium was added the following day under the
insert. After four days in culture fresh media with compounds 20 and 5 at 0.3 μM concentra-
tion compounds were added for six days long-term exposure. On day 10, the same compounds
were added in fresh medium at 1 μM concentration for the 4h short-term exposure. DMSO
was used as a negative control in both exposures. Cells were harvested by first washing the in-
serts with ice cold PBS, then incubating the isolated ECM slabs in ice cold 5 mM ethylenedi-
aminetetraacetic acid (EDTA) in PBS on ice on a table top rocker for 45 min to dissolve the
ECM, and finally by washing the cell pellets once with PBS before lysing them in Lysis Buffer 6
(R&D Systems, Minneapolis, MN, USA). The antibody arrays used were from the Human
Phospho-Kinase Array Kit (R&D Systems, Minneapolis, MN, USA). The samples were assayed
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according to manufacturer’s instructions. Exposed radiograms were scanned with a tabletop
scanner and spot intensities quantified using Array-Pro Analyzer (v4.5.1.73) software.
Supporting Information
S1 Fig. Summary of the results from High Throughput Screening of betulin derivatives and
abietanes in 2D cell culture conditions (384-well format). Screening data for cell lines PC3,
LNCaP and EP156T were measured as CellTitreGlo intensity, and normalized values were
combined into a single plot. Compounds named according to internal nomenclature. The run-
ning number for compounds selected for further experiments is shown in parentheses.
(EPS)
S2 Fig. Morphometric image analysis. A) Maximum intensity projections of two confocal
image stacks segmented with AMIDA image analysis program. The left image shows PC-3 cells
in their invasive phase cultured 10 days in 3DMatrigel ECM. The right image shows chemical-
ly suppressed invasion. B) A random sample of thousand observations plotted from the com-
plete data set and a robustly fitted regression line close to linear dependency indicating the
natural relationship between two morphological features log(Area) and log(Perimeter). Devia-
tions from this average (residuals) can then be interpreted as a measure for the shape complexi-
ty. C) A random sample of 40 structures ordered based on the complexity measure.
(TIF)
S3 Fig. Validation of anti-invasion effects of betulin derivatives. A) Graph showing the tran-
sition of PC-3 spheroids from symmetrical acini to irregular invasive structures over 6 days, as
measured by general symmetry (roundness %). Betulin derivatives 5 (left) and 20 (right) sup-
press the invasive transformation at concentrations over 300 nM. B) Conventional wound
healing assay performed in monolayer culture over a period of 64 hours. Wound closure is
measured as relative wound density i.e. percentage of original wound area reclaimed by migrat-
ing cells. 50% inhibition serving as a cut-off point for effectiveness is highlighted with an or-
ange dashed line.
(EPS)
S4 Fig. Secondary screens. Dendrograms for A) LNCaP, B) LAPC-4, and C) Ep156T betulin
screens in 3D culture have been constructed using three main read-outs: spheroid size, spher-
oid complexity, and cell death. Clusters highlighted with yellow and red color represent the
most biologically active compounds.
(EPS)
S5 Fig. Primary and secondary screens. The heatmap shows morphometric data from betulin
screens performed with four cell lines (PC-3, LNCaP, LAPC-4, Ep156T). The main read-outs
(Area = Size, Complexity = Invasiveness, Red = Cell death) are shown in their own columns.
Data scaling: DMSO control has been given a value 0 whereas paclitaxel control is valued -100
or 100 depending on the read-out. Color key is located in the upper right corner.
(EPS)
S6 Fig. Confocal images from primary and secondary betulin screens. Viable cells have been
stained with calcein AM (green) and dead cells with ethidium homodimer-2 (red) (5× objec-
tive, maximum intensity projections, scale bar = 100 μm).
(TIF)
S7 Fig. Positive control paclitaxel EC50 curves for proliferation, cell death and apoptosis in
monolayer culture. EC50values, calculated with PerkinElmer Harmony software, are displayed
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in each graph.
(TIF)
S8 Fig. Cell cycle, proliferation and mitotic analyses. A) Histograms for DNA content for the
cell lines PC-3, LNCaP and Ep156T; exposed to three betulin derivatives 4, 5 and 20 at 1 μM
concentration for 72 h in monolayer culture. Relative proportions of each cell cycle phase (G1,
S and G2), assessed using Flowing software (v2.5.1), are displayed next to each histogram (in
%). B) Expression of proliferating cell nuclear antigen (PCNA) and mitotic cyclin B1 protein in
response to 72h exposure to betulin derivatives. 24h paclitaxel treatment was used as mitotic
arrest control.
(TIF)
S9 Fig. Morphologies of PC-3, LNCaP and Ep156T cells in 2D monolayer culture, exposed
72h to selected betulin derivatives. Actin cytoskeleton (filamentous or F- actin) is stained
green (LifeAct), nuclei with a red dye (confocal microscope images, 40× objective, scale bar
shown for each panel on the right lower corner).
(TIF)
S1 File. Supplemental Methods.
(DOCX)
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